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Abstract
Background: Despite epidemiological evidences of relationship between poor lung function and atherosclerosis, the
relationship between poor lung function and microalbuminuria (MAU), an early surrogate marker of both kidney damage
and atherosclerosis, is not well understood. Hence, we plan to investigate the relationship between poor lung function and
MAU using multivariate models to adjust for other atherogenic risk factors.
Methods: We used data from the 5th Korean National Health and Nutrition Examination Survey. Poor lung function is
determined by spirometric measurement, primarily through estimation of the forced vital capacity (FVC) and forced
expiratory volume in 1 second (FEV1). Declines in the percent predicted FVC (,80%) and in the FEV1/FVC ratio (,0.7) are
defined as restrictive and obstructive patterns, respectively. Urine albumin to urine creatinine levels ratio (UACR) were
measured in spot urine samples. MAU was defined as UACR .30 mg/g.
Results: Inverse relationship was observed between lung function and UACR. In an age-adjusted regression model, the
regression coefficient (B) of 10% lower FVC was 11.09 in men (P= 0.002), which remained significant after adjustment for
SBP, FBG, triglyceride level, BMI, smoking history, and heavy alcohol consumption (B = 7.52, P= 0.043). When the restrictive
pattern was compared to the normal pattern, the odds ratios (OR) (95% confidence interval, 95%CI) for MAU were 1.90
(1.32–2.72) in men, after adjustment for age, hypertension, diabetes mellitus, triglyceride level, obesity, smoking history,
physical activity, and heavy alcohol consumption.
Conclusions: Our study, the first investigation in Asia, demonstrated that the restrictive pattern is related to MAU in men.
Furthermore, there was linear relationship between lower FVC and UACR. Thus, our current study suggests that poor lung
function, particularly the restrictive pattern, is related to kidney damage as well as atherosclerosis.
Citation: Yoon J-H, Won J-U, Ahn Y-S, Roh J (2014) Poor Lung Function Has Inverse Relationship with Microalbuminuria, an Early Surrogate Marker of Kidney
Damage and Atherosclerosis: The 5th Korea National Health and Nutrition Examination Survey. PLoS ONE 9(4): e94125. doi:10.1371/journal.pone.0094125
Editor: C. Mary Schooling, CUNY, United States of America
Received January 23, 2014; Accepted March 12, 2014; Published April 9, 2014
Copyright:  2014 Yoon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jhroh@yuhs.ac
Introduction
Microalbuminuria (MAU), as indicated by the urine albumin-
to-creatinine ratio (UACR), occurs when blood albumin leaks
from the kidneys into the urine [1]. This leakage also represents
underlying problems in blood vessels and specifically endothelial
dysfunction, a key mechanism of atherosclerosis [2]. Therefore,
microalbuminuria functions as an early surrogate marker of kidney
damage as well as a strong risk predictor of atherosclerosis or
cardiovascular diseases [3]. Furthermore, the strong predictive
power of MAU for the risk of atherosclerosis is independent of
conventional cardiovascular risk factors, even in diabetes mellitus
and hypertension patients [4].
Multiple pathological steps such as retention, modification, and
accumulation of lipids in the endothelium occur prior to vascular
damage or atherosclerosis, all of which are negatively influenced
by systemic inflammation [5]. Systemic inflammation is present in
various chronic disease states, including poor lung function [6].
Strong evidence indicates that poor lung function is a predictor of
the morbidity and mortality of atherogenic events [7], and
systemic inflammatory mechanisms are regarded as key mediators
of the strong relationship between poor lung function and
atherosclerosis [8].
Poor lung function is determined by spirometric measurement
of dynamic lung capacity, primarily through estimation of the
forced vital capacity (FVC) and forced expiratory volume in 1
second (FEV1). Clinically, a decline in the percent predicted FVC
(,80%) and in the FEV1/FVC ratio (,0.7) are key phenotypes of
restrictive and obstructive patterns of poor lung function,
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respectively. Both poor lung function patterns worsen detoxifica-
tion of systemic inflammation brought on by physical activity,
eventually resulting in persistent inflammatory status even after
rest [9]. Furthermore, when the inflammatory status persists in the
lung, a ‘‘spilling over’’ of inflammatory mediators from the lung to
systemic circulation occurs [10]. Eventually, extrapulmonary
organs such as bone, brain, and peripheral vasculature are
affected by inflammatory mediators arising from the lungs [11]. In
epidemiology studies, reduced FEV1 [12] as well as reduced FVC
[13] were linked to atherogenic mortality. Chronic obstructive
pulmonary disease (COPD), diagnosed when FEV1/FVC ratio is
,0.7, is also a manifestation of poor lung function status well
known to affect mortality due to atherogenic events [14].
Despite the epidemiological evidence of a relationship between
poor lung function and the risk of atherosclerosis, the relationship
between poor lung function and MAU, as an early surrogate
marker of both kidney damage and atherosclerosis, has not been
investigated. Tobacco smoking is a strong risk factor of both MAU
and poor lung function [15], and obesity, hypertension, and
diabetes mellitus are also risk factors of MAU. Therefore, whether
poor lung function is related to MAU after controlling for smoking
history, obesity, hypertension, and diabetes mellitus in multivariate
models remains unknown.
The aim of our study was to investigate the relationship between
poor lung function and MAU as an early surrogate marker of
kidney damage as well as atherosclerosis and thus, to generate
important information concerning the association between poor
lung function and MAU in an Asian population. We used a
multivariate model to adjust for obesity, hypertension, and
diabetes mellitus as well as the lifestyle factors of smoking history,
heavy alcohol consumption, and regular physical activity.
Methods
Ethics Statement
We used data from the 5th Korean National Health and
Nutrition Examination Survey (KNHANES). Data from 2011 to
2012 were selected for analysis. All voluntarily engaged partici-
pants provided written informed consent prior to their enrollment.
The participants’ records, except survey date and home region,
were anonymized prior to analysis. This study was approved by
the Institutional Review Board (IRB) of Korea Centers for Disease
Control and Prevention (IRB: 2011-02CON-06-C, 2012-01EXP-
01-2C).
5th KNHANE from 2010 to 2012
The Korea Centers for Disease Control and Prevention
conducted the 5th KNHANES from 2010 to 2012. A geographic
region based-multistage probability sampling of household units,
stratified according to sex and age, was undertaken throughout the
entire Korea population. Using the above sampling method, 192
household units consisting of 3,800 individuals were selected each
year, resulting in a total of 576 units with 11,400 individuals
included in the 5th KNHANES from 2010 to 2012. The response
rates in 2010, 2011, and 2012 were 81.9%, 80.4%, and 80.0%,
respectively. The KNHANES comprises 3 major examinations.
The first is a clinical health examination, including blood and
urine biochemistry analyses, blood pressure assessment, pulmo-
nary function tests, and roentgenography. The second is a
comprehensive self-reported questionnaire of anthropometric
and demographic characteristics such as health-related behaviors.
The third is a questionnaire on 24-hour recall of nutritional
information.
Pulmonary Function Testing and Poor Lung Function
Patterns
Spirometry tests to determine lung function patterns were
performed by trained technician using dry rolling-seal spirometers
(SensorMedics, Yorba Linda, USA) in participants older than 40 y
[16]. The technicians were trained according to American
Thoracic Society/European Respiratory Society criteria to review
the spirometry test results. Two criteria were applied to spirometry
data: (1) two or more acceptable spirometry curves to ensure
correct inspiration and 6-s expiration and (2) ,150-ml inter-
measurement variability in FVC and FEV1. The spirometry tests
were undertaken without a bronchodilator. Age, sex and height
adjusted normal predicted values of FVC and FEV1 in Korean general
population were used to calculate the values of % predicted FVC and FEV1
[17]. The restrictive pattern was defined as percent predicted
value of FVC ,80%, and the obstructive airflow pattern was
defined as FEV1/FVC ratio ,0.7.
Smoking History, Physical Activity, Heavy Alcohol
Consumption, and Obesity
Smoking status was categorized as non-smoker, former smoker,
and current smoker using a self-reported questionnaire. ‘‘Non-
smoker’’ was defined as a lifetime history of smoking fewer than
100 cigarettes. Regular physical activity was defined as more than
20 min of physical activity sufficient to cause sweating, 3 or more
times per week. Heavy alcohol consumption was defined as
drinking 7 or more glasses of alcohol on 2 or more occasions per a
week in men, and 5 or more glasses on 2 or more occasions per a
week in women.
Hypertension, Diabetes Mellitus, and Obesity
Hypertension was defined as blood pressure controlled using
pharmacological treatment or systolic blood pressure (SBP) or
diastolic blood pressure (DBP) exceeding 140 mmHg or
90 mmHg, respectively. Normal blood pressure was defined as
SBP below 120 mmHg and DBP below 80 mmHg. Participants
who fell below the hypertension threshold but above the threshold
for normal blood pressure were defined as prehypertension.
Diabetes mellitus was determined based on 8-h fasting blood
glucose (FBG). FBG levels less than 100 mg/dl, 100–125 mg/dl,
and 126 or above were defined as normal, glucose intolerance, and
diabetes mellitus, respectively. Participant with diabetes mellitus
controlled by pharmacological treatment were categorized as
diabetes mellitus regardless of FBG level. Body mass index (BMI),
the ratio of weight to squared height, was used for obesity
parameters [18], with underweight (,18.5 kg/m2), normal (18.5–
25.0 kg/m2), and overweight ($25.0 kg/m2) categorized as
dummy variables.
Urine Analysis for MAU
Spot urine samples were used to analyze MAU in KNHANES
[19]. Urine albumin and urine creatinine levels were measured in
spot urine samples, from which UACR was estimated. Urine
albumin and creatinine were determined using turbidimetric and
kinetic colorimetric assays, respectively, using a Hitachi Automatic
Analyzer 7600 (Hitachi, Japan). MAU was defined as UACR .
30 mg albumin/g creatinine.
Study Population for Data Analyses
Because UACR was measured from 2011 to 2012, 6,053
participants older than 40 y who completed UACR measurement
and spirometry testing were selected for analysis (2,885 in 2011
and 3,168 in 2012). We excluded 33 asthma patients receiving
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pharmacological treatment, because spirometry was not under-
taken after bronchodilation. Ultimately, a total of 6,020 partici-
pants (2,643 male and 3,377 female) were included in data
analyses.
Statistical Analysis
Frequency with percentage, mean with standard deviation (SD),
or median with interquartile range was used to interpret the
participant characteristics according to non-MAU vs. MAU status
as appropriate. Furthermore, age adjusted comparisons were
undertaken by using generalized linear model in table 1.
Regression coefficients of UACR were calculated with respect to
10% lower percent predicted FVC and FEV1 values in multiple
regression models. Odds ratios (ORs) with 95% confidence
intervals (95%CI) were calculated in multiple logistic regression
models according to poor lung function pattern (normal vs.
restrictive or obstructive pattern).
Results
Basic Characteristics of Participants According to MAU
(Table 1)
Participants with MAU of both sexes were older than those
without MAU (mean 6 SD; 57.1610.9 y vs. 60.8611 y, P,
0.001 in men; 57.7610.6 y vs. 61.8610.9 y, P,0.001 in women).
The proportion of poor lung function patterns differed between
the MAU and non-MAU groups. The proportions of restrictive
and obstructive patterns were higher in the MAU group than the
non-MAU group (restrictive pattern: 20.1% vs. 10.2%, P,
0.001 in men; 14.2% vs. 9.3%, P=0.004 in women; obstructive
pattern: 27.3% vs. 22.5%, P=0.002 in men; 8.8% vs. 6.0%,
P=0.033 in women). The percent predicted value of FVC in the
non-MAU group was higher than that in the MAU group for both
sexes (mean6 SD: 91.8%611.3 vs. 87%612.2, P,0.001 in men;
93.6%611.5 vs. 91.1%612.1, P,0.001 in women). The percent
predicted value of FEV1 in the non-MAU group was also higher
than that in the MAU group for men (mean 6 SD:
89.8%613.4 vs. 86.6%614.5, P,0.001 in men), but not for
women.
The proportion of participants with hypertension was higher in
the MAU group than in the non-MAU group for both sexes
(65.2% vs. 39.9%, P,0.001 in men; 65.5% vs. 35.2%, P,
0.001 in women, respectively). Mean SBP level was higher in the
MAU group than in the non-MAU group for both sexes (mean 6
SD: 123.2615.3 vs. 130.2616.6, P,0.001in men, 121.4616.9 vs.
132.2619.4, P,0.001 in women, unit =mmHg). The proportion
of participants with diabetes mellitus was greater in the MAU
group than in the non-MAU group for both sexes (38.9% vs.
11.9%, P,0.001 in men; 24.8% vs. 10.0%, P,0.001 in women).
Mean FBG level was higher in the MAU group than the non-
MAU group for both sexes (mean 6 SD: 101.9621 vs.
117.2636.3, P,0.001 in men; 97.9620.1 vs. 110.4627.8, P,
0.001 in women, unit =mg/dL). Median triglyceride level was
higher in the MAU group than in the non-MAU group for both
sexes (median [interquartile range]: 131.0 [92.0–194.0] vs. 145.0
[92.5–225.0], P=0.049 in men; 108.0 [75.0–155.5] vs. 126.0
[80.0–193.0], P,0.001 in women, unit =mg/dL). The proportion
of overweight women was higher in the MAU group than in the
non-MAU group (48.7% vs. 34.9%, P,0.001). No differences in
the lifestyle factors of smoking history, heavy alcohol consumption,
and physical activity were observed between participants with
MAU and without MAU of either sex.
In age-adjusted comparisons, mean DBP level is higher in MAU
group than that in non-MAU group for men (age adjusted P,
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0.019). But age adjusted comparison did not alter those significant
associations in the others variables.
Multivariate Regression Analyses for Urine Albumin/
creatinine Ratio According to Pulmonary Function
(Table 2)
An inverse relationship was observed between lung function and
UACR. In an age-adjusted regression model, the regression
coefficient (B) of 10% lower in predicted FVC was 11.09 in men
(P=0.002), which remained significant after adjustment for SBP,
FBG, triglyceride level, BMI, smoking history, and heavy alcohol
consumption (B= 7.52, P=0.043). The relationship was not
significant in women. No significant association between UACR
and FEV1 was observed in either sex.
Logistic Regression Models for MAU According to Poor
Lung Function Pattern (Table 3)
When the restrictive pattern was compared to the normal
pattern, the crude ORs (95%CI) for MAU were 2.60 (1.87–3.62)
in men and 1.55 (1.07–2.25) in women. That relationship
remained significant after adjustment for age in men (OR
[95%CI], 2.30 [1.64–3.22]) but not in women. Further adjustment
for hypertension, diabetes mellitus, triglyceride level, obesity,
smoking history, physical activity, and heavy alcohol consumption
did not attenuate that association in men (OR [95%CI], 1.90
[1.32–2.72]). The obstructive pattern was related to MAU in the
crude logistic regression model (OR [95%CI]: 1.52 [1.14–2.04] in
men; 1.73 [1.12–2.68] in women), but further adjustment for age
attenuated that association in both sexes. Hypertension and
diabetes mellitus were related to MAU in a multiple logistic
regression model (OR [95%CI]: 4.01 [2.60–6.19] and 3.96 [2.89–
5.41] in men; 3.18 [2.18–4.64] and 2.42 [1.71–3.42] in women).
In men, heavy alcohol consumption was related to the MAU in a
multiple logistic regression model (OR [95%CI]: 1.49 [1.03–
2.17]).
Discussion
Our current study shows that restrictive lung function pattern
was associated with MAU, an early surrogate marker of kidney
damage and atherosclerosis, in men. That relationship remained
significant even after adjustment for age, hypertension, diabetes
mellitus, triglyceride level, obesity (using body mass index),
smoking history, physical activity, and heavy alcohol consumption.
In a multivariate regression model, a linear relationship was
revealed between the lower predicted FVC and UACR, which was
not attenuated after controlling for conventional atherogenic risk
factors such as age, SBP, FBG, triglyceride level, BMI, smoking
history, and heavy alcohol consumption. To the best of our
knowledge, this study is the first investigation in Asia to examine
the relationship between poor lung function and MAU.
MAU and increased UACR are regarded as early predictors of
kidney damage as well as atherosclerosis [20]. MAU and increased
UACR indicate that blood albumin has leaked from blood vessels
of the kidneys into the urine. This leakage represents vascular
dysfunction, a key pathological step of vascular damage or
atherosclerosis in any organ. Hence, our current finding of an
inverse relationship between FVC and MAU is consistent with
evidence that poor lung function increased the risk of atheroscle-
rosis [7]. Some reports have demonstrated that the relationship
between poor lung function and risk of atherosclerosis is
attenuated after controlling for conventional risk factors of
atherosclerosis such as hypertension, diabetes mellitus, lipid
profile, and obesity [18]. Some study show that there was
significant association between poor lung function and impaired
fasting glucose [21]. Thus, whether poor lung function is related to
MAU when both hypertension and DM are incorporated into a
multivariate model remains controversial. However, the current
study revealed a strong relationship between poor lung function
and MAU or UACR even after controlling for age, hypertension
or SBP, diabetes mellitus or FBG, triglyceride level, obesity,
smoking history, physical activity, and heavy alcohol consumption.
The obstructive lung pattern manifests as COPD, and COPD
has been reported to increase systemic inflammation and elevate
the risk of atherogenic events [22]. The risk of cardiovascular
events increases according to the severity of COPD [23].
However, in contrast to the findings of a previous report, the
obstructive pattern was not related to MAU in the current study.
The obstructive pattern can be re-categorized according to its
severity using GOLD criteria [24], in which the mild, moderate,
and severe obstructive pattern is defined as percent predicted value
of FEV1.80%, .50%, and ,50%, respectively. The number
(and proportion) of mild, moderate, and severe cases of the
obstructive pattern in the current study was 291 (49.9%), 276
(47.3%), and 16 (2.7%) in men, and 102 (50.3%), 98 (48.3%), and
3 (1.5%) in women, respectively (data not shown in any table). The
number of cases of the severe obstructive pattern was insufficient
to reach statistical significance in the current study. Thus, although
we did not observe a relationship between the obstructive pattern
and MAU, it remains unclear whether the severe obstructive
pattern is related to MAU risk.
Table 2. Multivariate regression analyses for urine albumin/creatinine ratio by pulmonary function.
Model I Model II
B p value B p value
10% lower of predict FVC male 11.09 0.002 7.52 0.043
female 1.86 0.094 20.02 0.936
10% lower of predict FEV1 male 4.97 0.106 1.95 0.536
female 0.79 0.425 0.16 0.876
Model I: adjusted for age.
Model II: adjusted for age, systolic blood pressure, fasting blood glucose, triglyceride, obesity (using body mass index), smoking history, physical activity, heavy alcohol
drinking.
Physical activity: Regular physical activity is defined when the participant do .20 minutes and 3 times per week or more physical activity which causes sweating.
Heavy alcohol consumption: Severe alcohol drinker is defined when the participants drink 7 glasses or more alcohol per one time, and 2 times or more alcohol drinking
per a week in men (same as in men, 5 glasses or more in women is defined sever alcohol drinker).
doi:10.1371/journal.pone.0094125.t002
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In the current study, the restrictive pattern was strongly related
to MAU as an early indicator of kidney damage and atheroscle-
rosis. Although the pathological mechanism underlying this
relationship is not clear, previous reports have shown that lower
FVC is linked to atherogenic diseases [13,25]. Furthermore, some
reports have found reduced FVC to be associated with a greater
increase in the risk of atherogenic disease compared to severe
COPD [26]. FVC is reduced in patients with massive obesity,
which disrupts pulmonary compliance due to abdominal pressure
[27]. Chronic medical conditions such as diabetes and hyperten-
sion are also associated with the restrictive pattern, and mortality is
sharply increased when the restrictive pattern coexists with such
chronic conditions [28]. Obesity, hypertension, and diabetes
mellitus are linked to systemic inflammation, and thus, they are
strong atherogenic risk factors. Hence, these comorbidities may
partially explain the high atherogenic risk of the restrictive pattern.
However, in the current study, the restrictive pattern was
significantly related to MAU even after controlling for other
atherogenic risk factors, including obesity, diabetes mellitus,
hypertension, and the lifestyle factors of smoking, physical activity,
and heavy alcohol consumption. This result suggests that the
relationship between atherosclerosis and the restrictive pattern is
independent of these comorbidities.
Vascular damage and endothelial dysfunction are key mecha-
nisms of both atherosclerosis and kidney damage. Poor lung
function is also related to vascular damage and endothelial
dysfunction [29] through systemic inflammation [30]. However,
there is a lack of evidence concerning the relationship between
poor lung function and kidney damage in Asian populations, and
therefore, our study provides useful evidence on this topic. Our
current results suggest that poor lung function is associated with
kidney damage.
Sex differences were observed in the current study. The
restrictive pattern was significantly related to MAU in men but
not in women. We also observed a significant linear relationship
between lower FVC and UACR in men but not in women.
However, we did not find any suitable explanation for these sex
differences in the literature. Among participants demonstrating the
restrictive pattern (n = 604; 289 men and 315 women), the
proportion of cases with MAU was lower in women than in
men (n [%]: 42 [13.3%] vs. 62 [21.5%], P=0.008, respectively,
data not shown in any table). Additionally, the percent predicted
FVC of the MAU group was 87.0% in men and 91.1% in women
(P,0.001, data not shown in any table). Therefore, the lower
proportion of women with MAU and relatively better lung
function in women than in men may partially explain the lack of
statistical significance in women. However, to elucidate the
relationship between poor lung function and MAU in women, a
large sample size including participants with poor lung function is
needed.
The current study has several limitations. Due to the cross-
sectional study design, the direction of causality in our study is not
clear. However, evidence such as the ‘‘spilling over’’ theory
supports our current results. To summarize the ‘‘spilling over’’
theory, inhaled particles cause lung inflammation and oxidative
stress. When compensations to reduce inflammation and oxidative
stress are insufficient, inflammatory mediators spill over from the
lung to systemic circulation, subsequently exacerbating patholog-
ical change in extrapulmonary organs and causing chronic disease
such as ischemic heart disease, osteoporosis, anemia, and
depression [31]. Because systemic inflammation is a critical
mechanism underlying atherosclerosis, the hypothesis that the
relationship between poor lung function and MAU is mediated by
‘‘spilling over’’ of inflammatory mediators from the lung to
systemic circulation, including kidney vessels, is biologically
plausible. Hence, our current results are consistent with evidence
of a relationship between poor lung function and the risk of
vascular damage. Furthermore, our study revealed for the first
time that the scope of this vascular damage extends to kidney
damage. Low density lipoprotein and high density lipoprotein are
important lipid profiles for risk of atherosclerosis. However, we
used only triglyceride level to adjust lipid profiles, because we have
no data of other lipid profiles. Hence, further research using more
lipid profiles is needed to elucidate the relationship between poor
lung function and MAU.
Conclusion
Our study, the first investigation in Asia to report a relationship
between poor lung function and MAU, demonstrated that the
restrictive pattern is related to MAU, an early indicator of kidney
damage and atherosclerosis, in men. Thus, our current study
suggests that poor lung function, particularly the restrictive
pattern, is related to kidney damage as well as atherosclerosis.
Furthermore, the association remained significant after controlling
for conventional atherogenic risk factors such as age, hypertension,
diabetes mellitus, lipid profile, obesity, smoking history, and heavy
alcohol consumption.
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